JPRN-UMIN000001772CompletedPhase 2
The clinical study on immunotherapy for advanced renal cell carcinoma =Combination therapy of natural IFN-alfa and meloxicam against metastatic renal cell crcinoma= - Combination therapy with meloxicam, a COX-2 inhibitor, and interferon alfa for metastatic renal cell carcinoma
Hokkaido Advanced Renal Cell Carcinoma Treatment Group0 sites50 target enrollmentStarted: March 13, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
The combination of IFN-alfa and meloxicam is considered to be an effective therapy that achieves a higher response rate compared with that previously reported for IFN- monotherapy.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. prior immunotherapy 2. Brain metastasis 3. Bone metastasis alone 4. active double cancers 5. Liver cirrhosis 6. uncontolled DM 7. Depression
Investigators
Similar Trials
Not yet recruiting
Not Applicable
An integrated immunological-pharmacological approach to improve long-term allograft functiograft failurekidney transplantation10029149NL-OMON45414Inwendige Geneeskunde - Nefrologie en Transplantatie420
Terminated
Phase 1
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell LymphomaCutaneous T-cell LymphomaNCT02061449NYU Langone Health3
Terminated
Not Applicable
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory DiseasesInflammatory Bowel DiseasesNCT03370601University Hospital, Lille9
Completed
Phase 1
Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for MelanomaMelanomaNCT01608594Diwakar Davar30
Recruiting
Not Applicable
Combination therapy of interferon-alpha and interleukin-2 for patients with metastatic renal cell carcinoma after failure of targeted therapy because of adverse eventsJPRN-UMIN000017717Department of Urology, The University of Tokyo Hospital30